Dow Up0.96% Nasdaq Up1.73%

Enanta Pharmaceuticals, Inc. (ENTA)

-NMS
43.30 Down 3.29(7.06%) 11:52AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 42,051   2,160   893   1,349  
Cost of Revenue -   -   -   -  
Gross Profit 42,051   2,160   893   1,349  
Operating Expenses
Research Development4,553  4,722  4,263  4,300  
Selling General and Administrative2,603  2,565  2,087  1,750  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 34,895   (5,127) (5,457) (4,701)
Income from Continuing Operations
Total Other Income/Expenses Net41  (72)92  266  
Earnings Before Interest And Taxes34,936  (5,199)(5,365)(4,435)
Interest Expense5  4  5  8  
Income Before Tax34,931  (5,203)(5,370)(4,443)
Income Tax Expense(15,122) -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops50,053  (5,203)(5,370)(4,443)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 50,053   (5,203) (5,370) (4,443)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 50,053   (5,203) (5,370) (4,443)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.